Unraveling a Diagnostic Enigma: A TECPR2 Case Solved Through Multi‐Omic Genomics
Authors:
- Teresa ZhaoTZTeresa Zhao
- Andrew P. FennellAFAndrew P. Fennell
- Tanavi SharmaTSTanavi Sharma
- Katrina M. BellKBKatrina M. Bell
- Monique DunstanMDMonique Dunstan
- Sebastian LunkeSLSebastian Lunke
- Meagan J. McGrathMMMeagan J. McGrath
- Catriona McLeanCMCatriona McLean
- Undiagnosed Diseases Network (Udn‐Aus)U(Undiagnosed Diseases Network (Udn‐Aus)
- David R. ThorburnDTDavid R. Thorburn
- David A. StroudDSDavid A. Stroud
- John ChristodoulouJCJohn Christodoulou
Open Access
- 11 May 2026
- journal article
- case report
- Published by Wiley in American Journal of Medical Genetics Part A
- Vol. 200 (10) , 2338-2344
Abstract
TECPR2 is a key regulator of autophagy, encoded by the TECPR2 gene. Pathogenic variants in this gene have been linked to a rare hereditary sensory and autonomic neuropathy with intellectual disability (HSAN9). We report a teenage female with a syndromic intellectual disability disorder associated with neuromuscular abnormalities. Multi‐omics analysis including genomics, transcriptomics, and proteomics, together with muscle biopsy from the affected individual, were used in this clinical case. Through trio exome sequencing we identified two heterozygous variants in the TECPR2 gene, NM_014844.4: c.480G>A; p.(Gln160=) and c.2846C>A; p.(Ala949Glu). Both were classified as variants of uncertain significance due to the lack of supporting evidence for pathogenicity. Subsequent long‐read sequencing phased the variants and confirmed they were in trans . Additional functional studies using RNAseq and proteomics analyses verified the pathogenicity of the variants. This case study demonstrated the value of a multi‐omics assisted analysis, which complemented the traditional phenotype‐first approach in reaching a definitive clinical diagnosis.Keywords
Funding Information
- University of Melbourne
- Murdoch Children's Research Institute
- National Health and Medical Research Council (2009732)
- National Health and Medical Research Council (1155244)
- Medical Research Future Fund (2016030)
- Medical Research Future Fund (2007567)
- Medical Research Future Fund (2008820)
- Medical Research Future Fund (2015993)
- Mito Foundation
- Garvan Institute of Medical Research
- Australian Genomics Health Alliance
This publication has 12 references indexed in Scilit:
- LongPhase: an ultra-fast chromosome-scale phasing algorithm for small and large variantsBioinformatics, 2022
- New strategies to improve minimap2 alignment accuracyBioinformatics, 2021
- Clinical, neuroimaging, and molecular spectrum of TECPR2 ‐associated hereditary sensory and autonomic neuropathy with intellectual disabilityHuman Mutation, 2021
- Lysosomal targeting of autophagosomes by the TECPR domain of TECPR2Autophagy, 2020
- Genetic diagnosis of Mendelian disorders via RNA sequencingNature Communications, 2017
- TECPR2 Cooperates with LC3C to Regulate COPII-Dependent ER ExportMolecular Cell, 2015
- Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular PathologyGenetics in Medicine, 2015
- Mutation in TECPR2 Reveals a Role for Autophagy in Hereditary Spastic ParaparesisThe American Journal of Human Genetics, 2012
- Integrative genomics viewerNature Biotechnology, 2011
- Autophagy in the Pathogenesis of DiseaseCell, 2008